HETEROCYCLIC COMPOUND, AND HARMFUL-ARTHROPOD-CONTROLLING AGENT CONTAINING SAME

Title:

HETEROCYCLIC COMPOUND, AND HARMFUL-ARTHROPOD-CONTROLLING AGENT CONTAINING SAME

Document Type and Number:

WIPO Patent Application WO/2018/052119

Kind Code:

A9

Abstract:

The present invention pertains to a compound represented by formula (1) [In the formula, Q represents a group represented by Q1, Q2, or Q3, and T represents: a chain hydrocarbon group, alkoxyalkyl group, alkylsulfanylalkyl group, alkylsulfinylalkyl group, or alkylsulfonylalkyl group having a halogen atom; a cycloalkylalkyl group or cycloalkyl group having a substituent; or a group represented by OR1, S(O)mR1, OS(O)2R1, CH2OR1, NR1R29, C(O)R1, C(O)NR1R29, NR29C(O)R1, N=CR1R30, or formulae T-1 to T-12].

More Like This:

WO/2012/039262	CARBAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT MATERIAL AND ORGANIC SEMICONDUCTOR MATERIAL
JP6662885	Tetrazolone as a carboxylic acid bioisostere
JP2002536431	INDUSTRIAL APPLICABILITY Tyrosine Alkoxyguanidine as an integrin inhibitor

Inventors:

ORIMOTO KOHEI (JP)
SHIMOMURA MASARU (JP)

Application Number:

PCT/JP2017/033478

Publication Date:

June 06, 2019

Filing Date:

September 15, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SUMITOMO CHEMICAL CO (JP)

International Classes:

C07D409/04; A01N43/40; A01N43/90; A01P7/04; C07D471/04; C07D487/04

Attorney, Agent or Firm:

TANAI Sumio et al. (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: CORE DRILL

Next Patent: A HCK INHIBITOR AND A BCL-2 INHIBITOR FOR TREATING ACUTE MYELOID LEUKEMIA